In addition, Pat thinks then beginner investors should cultivate two important qualities: a healthy sense of skepticism and patience.
[text_ad]
Investors should approach all investments with a healthy sense of skepticism. This can help keep you out of fraudulent stocks that masquerade as high-quality stocks. It will also keep you out of legally operated, but poorly managed, companies that promise more than they can possibly deliver.
If you are a new investor, you should also realize that losing patience can cause you to sell your best choices right before a big rise. All too often, investors buy a promising stock just as it enters a period of price stagnation. Even the best-performing stocks run into these unpredictable phases from time to time. They move mainly sideways in a wide range for months or years before their next big rise begins. (Stock brokers often refer to these stocks as “dead money.”)
If you lack patience, you run a big risk of selling your best choices in the midst of one of these phases, prior to the next big move upward. If you lose patience and sell, you are particularly likely to do so in the low end of the trading range, when stock prices have weakened and confidence in the stock has waned.
[text_ad]
Telus’s cash flow should also continue to improve now that it has converted most of its legacy copper lines to high-speed, fibre-optic systems. At the same time, it has upgraded its wireless networks to ultrafast 5G speeds.
WSP’s projects—both recently completed and ongoing—are varied. They include a two-million-square-foot Children’s hospital in Atlanta; a 1,325 megawatts offshore wind farm in Italy; a 12-storey shipping centre in Hong Kong; and National Bank’s new head office, a 40-storey office tower in downtown Montreal.
Kenvue is the former Consumer Health segment of Johnson & Johnson (J&J), which set it up as an independent company in November 2021. In May 2023, the new company then completed an initial public offering, with J&J selling its interest in the business.
Today, Kenvue’s portfolio of consumer health products includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID and other iconic brands. It also owns brands Aveeno, Zyrtec, and Nicorette. Together, those products resulted in sales of $15.46 billion for 2024.